Name: Mersana Therapeutics, Inc. (MRSN) Balance Sheet
Creator: FinSpry

Mersana Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Mersana Therapeutics, Inc. (MRSN) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	107.75	174.56	128.89	177.95	255.09	99.79	70.13
Short-Term Investments	26.87	34.52	151.83	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	134.62	209.08	280.71	177.95	255.09	99.79	70.13
Accounts Receivable	0.00	0.00	30.00	0.00	0.00	0.00	0.46
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.28	4.97	8.51	10.95	3.49	0.00	0.00
Total Current Assets	136.90	214.06	319.22	188.90	258.58	101.33	74.31
Non-Current Assets
Property, Plant & Equipment (Net)	6.78	11.53	14.46	14.86	12.67	2.60	2.69
Other Non-Current Assets	0.98	0.48	0.66	2.36	2.15	1.45	1.50
Total Non-Current Assets	7.76	12.00	15.12	17.21	14.82	4.05	4.20
Total Assets	144.66	226.06	334.34	206.11	273.40	107.54	78.50
Current Liabilities
Accounts Payable	4.33	7.32	13.95	12.32	8.34	16.28	23.10
Short-Term Debt	12.50	2.08	0.00	0.00	0.00	0.00	0.00
Current Portion of Long-Term Debt	12.50	2.08	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	18.96	20.85	43.18	28.72	16.15	0.00	0.00
Deferred Revenue	22.17	28.15	30.61	3.94	3.99	0.00	0.00
Other Current Liabilities	0.64	1.84	0.99	0.24	0.09	0.09	0.13
Total Current Liabilities	62.46	63.64	91.53	47.52	30.00	24.07	69.43
Non-Current Liabilities
Long-Term Debt	10.95	23.15	24.93	24.63	4.98	4.88	0.00
Other Non-Current Liabilities	0.01	0.00	0.20	0.53	0.17	0.28	0.28
Total Non-Current Liabilities	91.71	125.52	150.75	36.85	15.31	5.15	0.28
Total Liabilities	154.17	189.16	242.28	84.37	45.31	29.22	69.71
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.01	0.00	0.00
Retained Earnings	-895.55	-826.36	-654.69	-450.48	-280.42	-192.37	-164.17
Accumulated Other Comprehensive Income	0.01	0.01	-0.15	0.00	0.00	0.03	-0.01
Additional Paid-in Capital	886.02	863.24	746.89	572.21	508.50	270.66	172.97
Shares Outstanding	4.63	4.83	4.21	2.95	0.00	0.00	0.00
Total Stockholders' Equity	-9.51	36.90	92.06	121.74	228.09	78.32	8.80
Total Liabilities & Equity	144.66	226.06	334.34	206.11	273.40	107.54	78.50